| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 20830-81-3 | 柔红霉素; 道诺霉素 | Daunorubicin; Daunomycin; (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione |  | C27H29NO10 | 详情 | 供应商 |
| 57852-57-0 | 盐酸依达比星; 去甲氧基柔红霉素盐酸盐 | Idarubicin hydrochloride; (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione hydrochloride |  | C26H27NO9.HCl | 详情 | 供应商 |
| 58957-92-9 | 依达比星; 伊达吡星; 4-去甲氧基柔红霉素 | Idarubicin HCl; 5,12-Naphthacenedione,9-acetyl-7-[(3-amino-2,3,6-trideoxy-a-l-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-,(7S-cis)-; 1-Demethoxydaunorubicin; 4-DMD; 4-Demethoxydaunomycin; 4-Demethoxydaunorubicin; Demethoxydaunorubicin; Idarubicin |  | C26H27NO9 | 详情 | 供应商 |
| 88465-80-9 | Arugomycin; 2,6-Epoxy-2H-naphthaceno[1,2-b]oxocin,arugomycin deriv.; 2-Butenedioic acid (2E)-, 4''''(11)-monoester with(2R,3S,4S,5S,6R,11S,13S,14R)-methyl 11-[[O-2,6-dideoxy-3-O-methyl-a-l-lyxo-hexopyranosyl-(1® 4)-O-2,6-dideoxy-3-O-methyl-a-l-lyxo-hexopyranosyl-(1® 4)-O-2,6-dideoxy-a-l-lyxo-hexopyranosyl-(1® 4)-2,6-dideoxy-3-O-methyl-a-l-lyxo-hexopyranosyl]oxy]-5-[[O-2,6-dideoxy-3-O-methyl-a-l-lyxo-hexopyranosyl-(1® 4)-O-2,3,6-trideoxy-3-C-methyl-3-nitro-b-L-ribo-hexopyranosyl-(1® 4)-O-2,6-dideoxy-a-l-lyxo-hexopyranosyl]oxy]-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,8,10,13-tetrahydroxy-6,13-dimethyl-9,16-dioxo-2,6-epoxy-2H-naphthaceno[1,2-b]oxocin-14-carboxylate |  | C80H112N2O37 | 详情 | 供应商 | |
| 75443-99-1 | 盐酸阿柔比星 | ACLARUBICIN HYDROCHLORIDE; ACLARUBICIN HYDROCHLORIDE; aclacinomycinahydrochloride; aclacinon; n-2-yl)-alpha-l-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-l-lyxo-hexopyrano; syl)oxy)-2,5,7-trihydroxy-,methylester,hydrochloride,(1r-(1-alpha,2-beta,4; 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-alpha-l-lyxo-hexopyranosyl]-3-(dimethylamino)-alpha-l-lyxo; 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-, meth; 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-, methyl ester, hydrochloride, [1R-(1α,2β,4β)]- |  | C42H54ClNO15 | 详情 | 供应商 |
| 69401-50-9 | 14-Hydroxy Carminomycin; (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-a-l-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-8-(hydroxyacetyl)-5,12-naphthacenedion; 14-Hydroxy Carminomycin; (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-8-(hydroxyacetyl)-5,12-naphthacenedione; Desmethyldoxorubicin; (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-a-l-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-8-(hydroxyacetyl)-5,12-naphthacenedione |  | C26H27NO11 | 详情 | 供应商 |
